A A

Clinical Trials

DAPT:
A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaeneous coronary intervention (PCI) with either drug-eluting  stent (DES) or bare metal stent (BMS) placement for the treatment of coronary artery lesions
Principal Investigator:
Charles Albert Shoultz III, MD.
Sub-Investigators:
William Pitts, MD.
Rodney Brown, MD.
Sherwin F. Attai, MD.
Sponsor:
Harvard Clinical Research Institute

THE COMPLETE SE-SFA STUDY:
The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries
Principal Investigator:
Rodney Brown, MD
Sub-Investigators:
Charles Albert Shoultz III, MD
Donald Cross, MD.
Sherwin F. Attai, MD
Sponsor:
Medtronic, Inc.

ACTIVE:   
Use of the Assurant Cobalt Iliac Balloon-Expandable Stent System in the Treatment of Iliac VEssel Disease) Study. 
Principal Investigator:
Rodney Brown, MD
Sub-Investigators:
Charles Albert Shoultz III, MD
Donald Cross, MD
Sherwin F. Attai, MD
Sponsor:
Medtronic, Inc.

VIRGO:
Variation in Recovery:  Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients.
Principal Investigators:
Charles Albert Shoultz III, MD
Funding Source:
National Heart Lung and Blood Institute
Sponsor:
Yale University School of Medicine

DEFINITIVE LE:
Determination of EFfectiveness of the SilverHawk® PerIpheral ®   Plaque ExcisioN System (SIlverHawk Device) for the Treatment of Infrainguinal VEssels/ Lower Extremities    
Principal Investigator:
Wayne Falcone, MD
Sponsor:
ev3 

CHOICE:
Carotid Stenting For High Surgical-Risk Patients; Evaluating Outcomes Through The Collection Of Clinical Evidence 
Principal Investigator:
Wayne Falcone, MD
Sub-Investigators:
Andrew Day, MD
David Hoffman, MD
Sponsor:
Abbott Vascular

GEL THE NEC:
Gaining Efficacy Long Term; HydroSoft, and Emerging, New Embolic Coil
Principal Investigator:
Adam Borowski, MD
Sponsor:
Mayo Clinic / MicroVention, Inc

RELIEF:
A prospective registry evaluating the number of patients with EF < 35 Referred for EP Consultant
Principal Investigator:
Charles Albert Shoultz III, MD
Sponsor:
Investigator Initiated Trial

SANTYL:
Comparison of Sharp Surgical Debidement versus Collagenase Santly® Ointment in the Care of Diabetic Foot Wounds
Principal Investigator:
Philip Croyle
Sponsor:
Healthpoint

PACE-MI REGISTRY:
Is a non-voluntary registry of consecutive patients diagnosed as having a MI at each study site.  In patient with MI discharged from the hospital, beta-blocker dose will be predictive of survival
Principal Investigator:
Charles Albert Shoultz III, MD.
Funding Source:
National Heart Lung and Blood Institute
Sponsor:
Northwestern University Chicago, IL